These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12931726)
21. The effects of phototherapy on the numbers of circulating natural killer cells and T lymphocytes in psoriasis. Tobin AM; Maguire B; Enright H; Kirby B Photodermatol Photoimmunol Photomed; 2009 Apr; 25(2):109-10. PubMed ID: 19292789 [TBL] [Abstract][Full Text] [Related]
24. BiP: a new biologic immunomodulator for the treatment of rheumatoid arthritis. Panayi G; Corrigall V Autoimmun Rev; 2004 Jun; 3 Suppl 1():S16-7. PubMed ID: 15309771 [No Abstract] [Full Text] [Related]
25. From conventional to cutting edge: the new era of biologics in treatment of psoriasis. Tzu J; Kerdel F Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087 [TBL] [Abstract][Full Text] [Related]
26. Psoriasis and Biologics. Introduction. Leonardi C Semin Cutan Med Surg; 2010 Mar; 29(1):1-2. PubMed ID: 20430300 [No Abstract] [Full Text] [Related]
27. [Adequate therapy of intestinal dysbacteriosis in children]. Bel'mer SV; Gasilina TV Klin Med (Mosk); 1998; 76(10):35-8. PubMed ID: 9865015 [No Abstract] [Full Text] [Related]
28. [Psoriasis. How much promise for immunobiologic therapy?]. Musch A Med Monatsschr Pharm; 2005 Aug; 28(8):262-6. PubMed ID: 16128537 [No Abstract] [Full Text] [Related]
29. Long-term data in the treatment of psoriasis. Thaçi D Br J Dermatol; 2008 Aug; 159 Suppl 2():18-24. PubMed ID: 18700911 [TBL] [Abstract][Full Text] [Related]
30. [Method of determining the sensitivity of lymphocytes to immunomodulators of the phenylimidazothiazole group]. Kazmirchuk VE; Bychkova NG; Andrushchuk AA; Giulling EV; Kravchuk GP Lab Delo; 1985; (3):169-71. PubMed ID: 2581051 [No Abstract] [Full Text] [Related]
31. Developments in systemic immunomodulatory therapy for psoriasis. Berger EM; Gottlieb AB Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886 [TBL] [Abstract][Full Text] [Related]
32. Adoptive immunotherapy after bone marrow transplantation in a patient with relapsed acute myeloid leukaemia and severe psoriasis. Windrum P; Jones FG; McMullin MF Bone Marrow Transplant; 2004 Aug; 34(3):281-2. PubMed ID: 15156169 [No Abstract] [Full Text] [Related]
33. [T-lymphocyte content in the blood in nephrotuberculosis under antibactertial and immunostimulation therapy]. Mukanbaev K; Vladimirskiĭ MA Probl Tuberk; 1980 Aug; (8):40-2. PubMed ID: 6967603 [No Abstract] [Full Text] [Related]
34. [Sorption therapy of psoriasis and indicators of the immune system during treatment]. Nesterenko GB; Usenko LV; Bashmakov GV; Kogon GKh; Ploskaia LM Vestn Dermatol Venerol; 1985 Oct; (10):41-4. PubMed ID: 3878638 [No Abstract] [Full Text] [Related]
36. Treating psoriasis as a T-cell mediated disease. Leonardi C Manag Care; 2004 Apr; 13(4 Suppl Treating Psoriasis):1, 3-8. PubMed ID: 15282980 [No Abstract] [Full Text] [Related]
37. [Interleukin-4: a new option in the therapy of systemic psoriasis?]. Homey B Hautarzt; 2003 Oct; 54(10):1019-20. PubMed ID: 14577420 [No Abstract] [Full Text] [Related]